Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.27
2.09
NAV
₹40.36
₹47.68
Fund Started
20 Jun 2019
25 Jun 2018
Fund Size
₹1010.54 Cr
₹6624.58 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
15.92%
8.10%
3 Year
22.27%
24.57%
5 Year
13.62%
15.96%
Equity
97.85%
96.05%
Cash
2.15%
3.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.09% |
Apollo Hospitals Enterprise Ltd. | 7.30% |
JB Chemicals & Pharmaceuticals Ltd. | 4.71% |
Torrent Pharmaceuticals Ltd. | 4.68% |
Aurobindo Pharma Ltd. | 4.55% |
Ajanta Pharma Ltd. | 4.38% |
Mankind Pharma Ltd. | 3.92% |
Lupin Ltd. | 3.74% |
Sai Life Sciences Ltd. | 3.50% |
Abbott India Ltd. | 3.26% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Jun 2019
25 Jun 2018
